Human Immunodeficiency Virus Proteinase Dimer As Component of the Viral Polyprotein Prevents Particle Assembly and Viral Infectivity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Apr 15

PMID 2014242

Citations 83

Authors

H G Krausslich

Affiliations

Soon will be listed here.

Abstract

Enzymatically active retroviral proteinases are dimers of identical polypeptide chains with a fold similar to that of other aspartic proteinases. Each polypeptide chain, encoded on one of the viral polyproteins, is less than half the size of cellular aspartic proteinases and contains only one of the two active-site aspartate residues. A plasmid was constructed to generate a genetically linked dimer of the proteinase (PR) of human immunodeficiency virus (HIV) type 1, composed of two copies of the PR sequence linked by a structurally flexible hinge region. The expression product was stable and active against HIV polyprotein substrates. Mutational analysis revealed that the linked dimer, and not multimers thereof, contained the proteolytic activity. Expression of the linked dimer as a component of a HIV polyprotein by in vitro translation gave rapid autocatalytic processing, whereas the wild-type polyprotein was stable on prolonged incubation. Transfection of HIV subviral or proviral constructs, containing the linked dimer of HIV PR, gave premature processing of the viral polyproteins, thus preventing particle formation and infectivity. Premature processing also led to increased cell toxicity.

Citing Articles

Mechanism and Kinetics of HIV-1 Protease Activation.

Tabler C, Tilton J Viruses. 2025; 16(12.

PMID: 39772135 PMC: 11680253. DOI: 10.3390/v16121826.

The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery.

Novotny P, Humpolickova J, Novakova V, Stanchev S, Strisovsky K, Zgarbova M J Biol Chem. 2024; 301(1):108079.

PMID: 39675720 PMC: 11773056. DOI: 10.1016/j.jbc.2024.108079.

HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.

Hsieh S, Yu F, Huang K, Wang C J Virol. 2023; 97(9):e0094823.

PMID: 37671867 PMC: 10537780. DOI: 10.1128/jvi.00948-23.

Structure of the HIV immature lattice allows for essential lattice remodeling within budded virions.

Guo S, Saha I, Saffarian S, Johnson M Elife. 2023; 12.

PMID: 37435945 PMC: 10361719. DOI: 10.7554/eLife.84881.

Neutral sphingomyelinase 2 is required for HIV-1 maturation.

Waheed A, Zhu Y, Agostino E, Naing L, Hikichi Y, Soheilian F Proc Natl Acad Sci U S A. 2023; 120(28):e2219475120.

PMID: 37406093 PMC: 10334776. DOI: 10.1073/pnas.2219475120.

References

Moffatt B, Studier F . T7 lysozyme inhibits transcription by T7 RNA polymerase. Cell. 1987; 49(2):221-7. DOI: 10.1016/0092-8674(87)90563-0. View

Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A . Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. PMC: 253077. DOI: 10.1128/JVI.59.2.284-291.1986. View

Rosenberg A, Lade B, Chui D, Lin S, Dunn J, Studier F . Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene. 1987; 56(1):125-35. DOI: 10.1016/0378-1119(87)90165-x. View

Jacks T, Power M, Masiarz F, Luciw P, Barr P, Varmus H . Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 1988; 331(6153):280-3. DOI: 10.1038/331280a0. View

Leis J, Baltimore D, Bishop J, Coffin J, Fleissner E, Goff S . Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol. 1988; 62(5):1808-9. PMC: 253234. DOI: 10.1128/JVI.62.5.1808-1809.1988. View

Kohl N, Emini E, Schleif W, Davis L, Heimbach J, Dixon R . Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A. 1988; 85(13):4686-90. PMC: 280500. DOI: 10.1073/pnas.85.13.4686. View

Krausslich H, Schneider H, Zybarth G, Carter C, Wimmer E . Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J Virol. 1988; 62(11):4393-7. PMC: 253881. DOI: 10.1128/JVI.62.11.4393-4397.1988. View

Krausslich H, Wimmer E . Viral proteinases. Annu Rev Biochem. 1988; 57:701-54. DOI: 10.1146/annurev.bi.57.070188.003413. View

Doffinger R, Pawlita M, Sczakiel G . Electrotransfection of human lymphoid and myeloid cell lines. Nucleic Acids Res. 1988; 16(24):11840. PMC: 339138. DOI: 10.1093/nar/16.24.11840. View

10.

Felber B, Cladaras C, Athanassopoulos A, Tse A, Pavlakis G . The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol. 1989; 63(3):1265-74. PMC: 247823. DOI: 10.1128/JVI.63.3.1265-1274.1989. View

11.

Krausslich H, Ingraham R, Skoog M, Wimmer E, Pallai P, Carter C . Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc Natl Acad Sci U S A. 1989; 86(3):807-11. PMC: 286566. DOI: 10.1073/pnas.86.3.807. View

12.

Malim M, HAUBER J, Le S, Maizel J, Cullen B . The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 1989; 338(6212):254-7. DOI: 10.1038/338254a0. View

13.

Loeb D, Swanstrom R, Everitt L, Manchester M, Stamper S, HUTCHISON 3rd C . Complete mutagenesis of the HIV-1 protease. Nature. 1989; 340(6232):397-400. DOI: 10.1038/340397a0. View

14.

Wlodawer A, Miller M, Jaskolski M, Sathyanarayana B, Baldwin E, Weber I . Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 1989; 245(4918):616-21. DOI: 10.1126/science.2548279. View

15.

Hellen C, Krausslich H, Wimmer E . Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry. 1989; 28(26):9881-90. DOI: 10.1021/bi00452a001. View

16.

Shoeman R, Honer B, Stoller T, Kesselmeier C, Miedel M, Traub P . Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sci U S A. 1990; 87(16):6336-40. PMC: 54528. DOI: 10.1073/pnas.87.16.6336. View

17.

DiIanni C, Davis L, Holloway M, Herber W, Darke P, Kohl N . Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease. J Biol Chem. 1990; 265(28):17348-54. View

18.

Ratner L, Haseltine W, Patarca R, Livak K, Starcich B, Josephs S . Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 1985; 313(6000):277-84. DOI: 10.1038/313277a0. View

19.

Kunkel T . Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985; 82(2):488-92. PMC: 397064. DOI: 10.1073/pnas.82.2.488. View

20.

Harada S, Koyanagi Y, Yamamoto N . Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 1985; 229(4713):563-6. DOI: 10.1126/science.2992081. View